Detalhe da pesquisa
1.
The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study.
Breast Cancer Res Treat
; 203(3): 497-509, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37938495
2.
Mucinous ovarian carcinoma: A survey of practice in Australia and New Zealand.
Aust N Z J Obstet Gynaecol
; 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38299485
3.
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trial.
Br J Cancer
; 129(5): 797-810, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37474720
4.
Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer.
Breast Cancer Res Treat
; 198(1): 67-74, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36624321
5.
Business as unusual: medical oncology services adapt and deliver during COVID-19.
Intern Med J
; 51(5): 673-681, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34047023
6.
Heart Failure in Breast Cancer Survivors: Focus on Early Detection and Novel Biomarkers.
Curr Heart Fail Rep
; 18(6): 362-377, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34731413
7.
Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer.
Breast Cancer Res Treat
; 184(1): 87-95, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32779037
8.
Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 20(9): 1226-1238, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31402321
9.
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.
N Engl J Med
; 372(10): 923-32, 2015 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25738668
10.
Nucleotide excision repair protein ERCC1 and tumour-infiltrating lymphocytes are potential biomarkers of neoadjuvant platinum resistance in high grade serous ovarian cancer.
Gynecol Oncol
; 151(2): 306-310, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30194007
11.
Supportive care of women with breast cancer: key concerns and practical solutions.
Med J Aust
; 205(10): 471-475, 2016 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27852186
12.
Aromatase inhibitor induced musculoskeletal syndrome: a significant problem with limited treatment options.
Support Care Cancer
; 24(5): 2139-2146, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26556210
13.
Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase II study.
Invest New Drugs
; 31(5): 1345-54, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23801303
14.
Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study.
Clin Breast Cancer
; 22(7): e764-e772, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35941066
15.
Results of PD-L1 Analysis of Women Treated with Durvalumab in Advanced Endometrial Carcinoma (PHAEDRA).
Cancers (Basel)
; 15(1)2022 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36612250
16.
Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial.
J Immunother Cancer
; 9(6)2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34103352
17.
Nerve growth factor and its receptor tyrosine kinase TrkA are overexpressed in cervical squamous cell carcinoma.
FASEB Bioadv
; 2(7): 398-408, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32676580
18.
Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230.
J Natl Cancer Inst
; 111(2): 210-213, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30371800
19.
Adipose-Derived VEGF-mTOR Signaling Promotes Endometrial Hyperplasia and Cancer: Implications for Obese Women.
Mol Cancer Res
; 16(2): 309-321, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29133593
20.
Overactive mTOR signaling leads to endometrial hyperplasia in aged women and mice.
Oncotarget
; 8(5): 7265-7275, 2017 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-27980219